Mettler-Toledo International Inc. (NYSE:MTD - Free Report) - Zacks Research cut their Q2 2025 EPS estimates for shares of Mettler-Toledo International in a research report issued on Thursday, May 22nd. Zacks Research analyst R. Department now forecasts that the medical instruments supplier will post earnings of $9.55 per share for the quarter, down from their previous estimate of $10.18. The consensus estimate for Mettler-Toledo International's current full-year earnings is $42.71 per share. Zacks Research also issued estimates for Mettler-Toledo International's Q4 2026 earnings at $14.08 EPS, FY2026 earnings at $45.83 EPS, Q1 2027 earnings at $10.55 EPS and FY2027 earnings at $54.17 EPS.
Several other brokerages have also recently issued reports on MTD. Wall Street Zen cut shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Wells Fargo & Company boosted their price objective on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research note on Monday, May 5th. UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and dropped their price objective for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Evercore ISI upped their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a research note on Monday, February 10th. Finally, Robert W. Baird lowered their price target on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 22nd. Seven analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, Mettler-Toledo International currently has an average rating of "Hold" and an average target price of $1,302.11.
View Our Latest Report on MTD
Mettler-Toledo International Stock Performance
MTD traded up $15.76 during trading on Monday, hitting $1,173.26. The stock had a trading volume of 65,129 shares, compared to its average volume of 180,574. The firm has a market capitalization of $24.38 billion, a P/E ratio of 28.95, a PEG ratio of 3.30 and a beta of 1.40. The company's 50-day moving average price is $1,095.35 and its 200 day moving average price is $1,207.36. Mettler-Toledo International has a twelve month low of $946.69 and a twelve month high of $1,546.93.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. The business had revenue of $883.74 million for the quarter, compared to analysts' expectations of $876.61 million. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The company's quarterly revenue was down 4.6% on a year-over-year basis. During the same period in the previous year, the company posted $8.89 EPS.
Institutional Investors Weigh In On Mettler-Toledo International
Institutional investors and hedge funds have recently made changes to their positions in the business. SBI Securities Co. Ltd. purchased a new stake in shares of Mettler-Toledo International in the 4th quarter worth about $33,000. WPG Advisers LLC purchased a new stake in shares of Mettler-Toledo International in the 1st quarter worth about $41,000. Edmond DE Rothschild Holding S.A. purchased a new stake in shares of Mettler-Toledo International in the 4th quarter worth about $44,000. Zions Bancorporation National Association UT purchased a new stake in shares of Mettler-Toledo International in the 1st quarter worth about $43,000. Finally, Blue Trust Inc. boosted its position in shares of Mettler-Toledo International by 70.8% in the 4th quarter. Blue Trust Inc. now owns 41 shares of the medical instruments supplier's stock worth $50,000 after buying an additional 17 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.
About Mettler-Toledo International
(
Get Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Read More

Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.